Canopy Growth Corporation Q4 FY2026 Financial Results

Canopy Growth Corporation announced its financial results for the fiscal fourth quarter and full year ended March 31, 2026. The company reported a consolidated net revenue of $71.2M in Q4 FY2026, a 10% increase year-over-year, and $284.6M for the full year, a 6% increase. Cannabis net revenue saw significant growth, with Canada medical cannabis up 27% in Q4 and 20% for the full year, and Canada adult-use cannabis up 1% in Q4 and 20% for the full year. International markets cannabis revenue increased by 68% in Q4, though decreased by 7% for the full year. Storz & Bickel net revenue decreased by 14% in both Q4 and the full year. The company reported a consolidated gross margin of 12% in Q4 FY2026, down from 16% in the prior year, and 24% for the full year, down from 30%. Adjusted gross margin improved significantly in Q4. The company incurred $67.1M in asset impairment and restructuring costs in FY2026. Net loss from continuing operations narrowed by 21% in Q4 and 49% for the full year. Adjusted EBITDA loss improved by 32% in Q4 and 14% for the full year. Free cash outflow improved from $176.6M in FY2025 to $69.1M in FY2026. The company ended the fiscal year with $131.3M in net cash, a significant improvement from net debt of $172.6M in the prior year. Canopy Growth completed the acquisition of MTL Cannabis and expects to achieve positive Adjusted EBITDA in FY2027.